// App-Quantinova.ai

AB1299 (2022) : DIFFERENCES IN THE CLINICAL SPECTRUM OF HAPLOINSUFFICIENCY OF A20 (HA20) CASES DIAGNOSED DURING ADULTHOOD

Researchers

Presenter

  • S. Amikishiyev

Principal Investigators

  • N. Aliyeva

  • M. Bektas

  • N. Koca

  • L. Soltanova

  • Y. Yalinkaya

  • B. Artim-Esen

  • M. Inanc

  • A. Gl

Medical Centers

  • Istanbul Faculty of Medicine, Istanbul University, Department of Cardiology, İstanbul, Turkey

  • Istanbul Faculty of Medicine, Istanbul University, Department of Internal Medicine, Istanbul, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Blood/haematological Diseases

Disease

  • Lymphocytopenia

  • Inflammatory Arthritis

  • Lupus

Biomarkers

  • 18F-fluorodeoxyglucose

  • anti-CCP antibodies

  • C reactive protein

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Hydroxychloroquine

  • Methylprednisolone

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

  • Tocilizumab

  • canakinumab (SC)

  • Tasocitinib

  • Adalimumab

  • Infliximab

  • Etanercept

  • CHS-0214

  • Colchicine

  • Abatacept

  • Belimumab

  • Rituximab

  • Anakinra

  • HA20

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved